- Report
- October 2024
- 200 Pages
Global
From €3357EUR$3,750USD£2,932GBP
- Report
- May 2024
- 200 Pages
Global
From €3715EUR$4,150USD£3,245GBP
- Report
- May 2024
- 200 Pages
Global
From €3715EUR$4,150USD£3,245GBP
- Report
- May 2024
- 200 Pages
Global
From €3715EUR$4,150USD£3,245GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1790EUR$2,000USD£1,564GBP
- Report
- January 2024
- 120 Pages
Global
From €7116EUR$7,950USD£6,216GBP
- Report
- April 2023
- 399 Pages
Global
From €8504EUR$9,500USD£7,428GBP
- Report
- July 2024
- 171 Pages
Global
From €4028EUR$4,500USD£3,519GBP
- Report
- September 2023
- 115 Pages
Global
From €4028EUR$4,500USD£3,519GBP
- Report
- May 2023
- 120 Pages
Global
From €4028EUR$4,500USD£3,519GBP
- Report
- June 2024
- 140 Pages
Europe
From €3463EUR$3,869USD£3,025GBP
- Report
- April 2023
- 147 Pages
Global
From €4430EUR$4,949USD£3,870GBP
- Report
- April 2022
- 64 Pages
Global
From €3133EUR$3,500USD£2,737GBP
- Report
- December 2023
- 150 Pages
Global
From €3983EUR$4,450USD£3,479GBP
From €3088EUR$3,450USD£2,698GBP
- Report
- August 2023
- 1300 Pages
Global
From €7967EUR$8,900USD£6,959GBP
- Report
- March 2025
- 150 Pages
Global
From €4341EUR$4,850USD£3,792GBP
- Report
- October 2025
- 90 Pages
Kuwait
From €4341EUR$4,850USD£3,792GBP
- Report
- October 2025
- 82 Pages
Qatar
From €4341EUR$4,850USD£3,792GBP
- Report
- November 2024
- 82 Pages
Global
From €4476EUR$5,000USD£3,909GBP

CRISPR Therapeutics is a rapidly growing field within the genomics market. It is a gene-editing technology that uses a modified version of the CRISPR-Cas9 system to modify or replace genes in a living organism. This technology has the potential to revolutionize the way diseases are treated, as it can be used to target and modify specific genes that are responsible for certain diseases. It can also be used to create new treatments for diseases that have no existing treatments.
CRISPR Therapeutics has been used to develop treatments for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. It has also been used to create new treatments for rare diseases, as well as to develop new therapies for existing diseases.
Companies in the CRISPR Therapeutics market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Caribou Biosciences. These companies are working to develop treatments for a variety of diseases, as well as to create new therapies for existing diseases. Show Less Read more